Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence

Clinical Nephrology

Volumn 71, Issue 1, 2009, Pages 1-8

  Shiekh, F A ^a   Miller, V M ^a   Lieske, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Calcium oxalate; Nanobacteria; Nanoparticles; Nephrolithiasis

Indexed keywords

CALCIUM OXALATE; DNA; LIPID; NANOPARTICLE; PROTEIN; RNA;

ACINETOBACTER; ARCHAEBACTERIUM; BIOFILM; BIOMINERALIZATION; CELL CULTURE; CHRONIC INFLAMMATION; CRYSTALLIZATION; CYTOTOXICITY; DISEASE MODEL; ELECTRON MICROSCOPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CALCIFICATION; KIDNEY INTERSTITIUM; MAMMAL CELL; MICROORGANISM; MORPHOLOGY; NEPHROLITHIASIS; NONHUMAN; PARTICLE SIZE; PATHOGENESIS; PROTEOMICS; PROTEUS; REVIEW; STONE FORMATION; URINARY TRACT INFECTION; CALCINOSIS; CHEMISTRY; MICROBIOLOGY; PATHOLOGY;

CALCINOSIS; HUMANS; NANOPARTICLES; NEPHROLITHIASIS;

EID: 63249121479     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71001     Document Type: Review

References (61)

1. Abbott A. Battle lines drawn between "nanobacteria" researchers. Nature. 1999; 401: 105.
2. Agababov RM, Abashina TN, Suzina NE, Vainshtein MB, Schwartsburd PM. Link between the early calcium deposition in placenta and nanobacterial-like infection. J Biosci. 2007; 32: 1163-1168.
3. Aihara K, Byer KJ, Khan SR. Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species. Kidney Int. 2003; 64: 1283-1291.
4. Akerman KK, Kuikka JT, Ciftcioglu N, Parkkinen J, Bergstrom KA, Kuronen I, Kajander EO. Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc SPIE. 1997; 3111: 436-442.
5. Baker BJ, Tyson GW, Webb RI, Flanagan J, Hugenholtz P, Allen EE, Banfield JF. Lineages of acidophilic Archaea revealed by community genomic analysis. Science. 2006; 314: 1933-1935.
6. Barrat JA, Gillet P, Lecuyer C, Sheppard SM, Lesourd M. Formation of carbonates in the Tatahouine meteorite. Science. 1998; 280: 412-414.
7. Benzerara K, Menguy N, Guyot F, Dominici C, Gillet P. Nanobacteria-like calcite single crystals at the surface of the Tataouine meteorite. Proc Natl Acad Sci USA. 2003; 100: 7438-7442.
8. Benzerara K, Miller VM, Barell G, Kumar V, Miot J, Brown GE Jr., Lieske JC. Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy. J Invest Med. 2006; 54: 367-379.
9. Björklund M, Ciftcioglu N, Kajänder EO. Extraordinary survival of nanobacteria under extreme conditions. SPIE. 1998; 3441: 123-129.
10. Brasier MD, Green OR, Jephcoat AP, Kleppe AK, Van Kranendonk MJ, Lindsay JF, Steele A, Grassineau NV. Questioning the evidence for Earth's oldest fossils. Nature. 2003; 416: 76-81.
11. Ciftcioglu N, Pelttari A, Kajander EO. Extraordinary growth phases of nanobacteria isolated from mammalian blood. SPIE. 1997; 3111: 429-435.
12. Ciftcioglu N, Kajander EO. Interaction of nanobacteria with cultured mammalian cells. Pathophysiology. 1998; 4: 259-270.
13. Ciftcioglu N, Björklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 1999; 56: 1893-1898.
14. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother. 2002; 46: 2077-2086.
15. Ciftcioglu N, Haddad RS, Golden DC, Morrison DR, McKay DS. A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int. 2005; 67: 483-491.
16. Cisar JO, Xu D-Q, Thompson J, Swaim W, Hu L, Kopecko DJ. An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA. 2000; 97: 11511-11515.
17. Conte Visus A, Grases Freixedas F, Costa-Bauza A, Piza Reus P. Microinfections and kidney lithiasis. Arch Esp Urol. 2001; 54: 855-860.
18. Donaldson K, Stone V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita. 2003; 39: 405-410.
19. du Toit PJ, van Aswegen CH, Nel JA, Steyn PL, Ligthelm AJ, du Plessis DJ. In vivo effects of urease-producing bacteria involved with the pathogenesis of infection-induced urolithiasis on renal urokinase and sialidase activity. Urol Res. 1995; 23: 335-338.
20. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003; 111: 602-605.
21. Folk RL. Bacteria and nanobacteria revealed in hard-grounds, calcite cements, native sulfur, sulfide minerals, and travertines. Geological Society of America Annual Meeting, Abstractswith Programs. 1992; 24: 104.
22. Folk RL. SEM imaging of bacteria and nanobacteria in carbonate sediments and rocks. J Sediment Petrol. 1993; 63: 990-999.
23. Garcia-Cuerpo E, Olavi Kajander E, Ciftcioglu N, Lovaco Castellano F, Correa C, Gonzalez J, Mampaso F, Liano F, Garcia de Gabiola E, Escudero Barrilero A. Nanobacteria. An experimental neolithogenesis model. Arch Esp Urol. 2000; 53: 291-303.
24. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, Jones ML, Caughey RC, Brown R, Millikin PD, Darras FS. Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int. 2000; 57: 2360-2374.
25. Huber H, Hohn MJ, Rachel R, Fuchs T, Wimmer VC, Stetter KO. A new phylum of Archaea represented by a nanosized hyperthermophilic symbiont. Nature. 2002; 417: 63-67.
26. Jones JA, Jennings R, Pietryzk R, Ciftcioglu N, Stepaniak P. Genitourinary issues during spaceflight: a review. Int J Impot Res. 2005; 17 (Suppl 1): S64-S67.
27. Kajander EO, Tahvaninen E, Kuronen I, Ciftcioglu N. Comparison of staphylococci and novel bacteria-like particles from blood. In: Molbly F, Nord C (eds). Staphylococci and staphylococcal infections. Stockholm, Sweden: Gustav Fischer Verlag. 1992; 147-149.
28. Kajander EO, Kuronen I, Akerman K, Pelttari A, Ciftcioglu N. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. SPIE. 1997; 3111: 420-428.
29. Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA. 1998; 95: 8274-8279.
30. Khullar M, Sharma SK, Singh SK, Bajwa P, Sheikh FA, Relan V, Sharma M. Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res. 2004; 32: 190-195.
31. Kirkland BL, Lynch FL, Rahnis MA, Folk RL, Molinex IJ, McLean R. Alternative origins for nanobacteria-like objects in calcite. Geology. 1999; 27: 347-350.
32. Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, Rzewuska E, Miller VM, Lieske JC. Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Invest Med. 2006; 54: 412-424.
33. Mandel N. Mechanism of stone formation. Semin Nephrol. 1996; 16: 364-374.
34. Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. J Urol. 1989; 142: 1513-1515.
35. Maniloff J. Nanobacteria: size limits and evidence. Science. 1997; 276: 1777.
36. McKay DS, Gibson EK Jr, Thomas-Keprta KL, Vali H, Romanek CS, Clemett SJ, Chillier XD, Maechling CR, Zare RN. Search for past life on Mars: possible relic biogenic activity in Martian meteorite ALH84001. Science. 1996; 273: 924-930.
37. Miller VM, Rodgers G, Charlesworth JA, Kirkland BL, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR 3rd, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC. Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol. 2004; 287: H1115-1124.
38. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone replacement therapy with various cardiovascular risk factors in post-menopausal women. N Engl J Med. 1993; 328: 1069-1075.
39. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006; 311: 622-627.
40. Netelenbos J, Zwijnenburg P, ter Wee P. Risk factors determining active urinary stone formation in patients with urolithiasis. Clin Neph. 2005; 63: 188-192
41. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005; 113: 823-839.
42. Phillips SE, Milnes AR, Poster RC. Calcified filaments: an example of biological influences in the formation of calcrete in South Australia. Aust J Soil Res. 1987; 25: 405-428.
43. Psenner R, Loferer M. Nanobacteria: size limits and evidence. Science. 1997; 276: 1776-1777.
44. Rahman NU, Meng MV, Stoller ML. Infections and urinary stone disease. Curr Pharm Res. 2003; 9: 975-981.
45. Randall A. The origin and growth of renal calculi. Ann Surg. 1937; 105: 1009-1020.
46. Raoult D, Drancourt U, Azza S, Nappez C, Guieu R, Rolain JM, Fourquet P. Campagna B, La Scola B, Mege JL, Mansuelle P, Lechevalier E, Berland Y, Gorvel JP, Renesto P. Nanobacteria are mineralo fetuin complexes. PLoS Pathol. 2008; 4: e41.
47. Rappe MY, Connon SA, Vergin KL, Giovannoni SJ. Cultivation of the ubiquitous SAR11 marine bacterioplankton clade. Nature. 2002; 418: 630-633.
48. Rieu P. Infective lithiasis. Ann Urol (Paris). 2005; 39: 16-29.
49. Sedivy R, Battistutti WB. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. Apmis. 2003; 111: 951-954.
50. Shen Y, Zhang Q, Chen L, Xie A, Kong X, Yang L. Effect of Escherichia coliform on the biomineralization of calcium bilirubinate in mimic systems. Colloids Surf B Biointerfaces. 2008; 65: 11-17.
51. Shiekh FA, Khullar M, Singh SK. Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res. 2006; 34: 53-57.
52. Sierakowski P, Finlayson B, Landes RR, Finlayson CD, Sierakowski N. The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol. 1978; 15: 438-441.
53. Simonelli AB, Englert GE, Campos K, Mergener M, de David C, de Olivera AP. Nanobacteria-like particles - a threat to cell cultures. Braz J Microbiol. 2007; 38: 153-158.
54. Thirman KV. The Life of Bacteria. New York: McMillan; 1963.
55. Torrella F, Morita RY. Microcultural study of bacterial size changes and microcolony and ultramicrocolony formation by heterotrophic bacteria in seawater. Appl Environ Microbiol. 1981; 41: 518-527.
56. Tsurumolo T, Matsumoto T, Yonekura A, Shindo H. Nanobacteria-like particles in human arthritic synovial fluids. J Protcome Res. 2006; 5: 1276-1278.
57. Verkoelen CF, Schepers SJ. Changing concepts in the aetiology of renal stones. Curr Opin Urol. 2000; 10: 539-544.
58. Vogel G. Bacteria to blame for kidney stones? Science. 1998; 281: 153.
59. Wainwright M. Extreme pleomorphism and the bacterial life cycle: a forgotten controversy. Perspect Biol Med. 1997; 40: 407-414.
60. Wen Y, Li YG. Yang ZL, Wang XJ, Wei H, Liu W, Miao XY, Wang QW, Huang SF, Yang J, Kajander EO, Ciftcioglu N. Detection of nanobacteria in senim, bile and gall-bladder mucosa of patients with cholecystolithiasis. Chin Med J (Engl). 2005; 118: 421-424.
61. Zeng JF, Zhang W, Jiang HW, Ling JQ. Isolation, cultivation and initial identification of nanobacteria from dental pulp stone. Zhonghua Kou Qiang Yi Xue Za Zhi. 2006; 41: 498-501.